3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Neoplasm Metastasis
2
von Hippel-Lindau Disease
1
Unilateral Breast Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymus Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrence
1
Neuroendocrine Tumors
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Liposarcoma
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Hamartoma Syndrome, Multiple
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Bone Neoplasms
1
Autistic Disorder
1
Astrocytoma
1
Advanced Lung Neuroendocrine Tumor
1
Interventions
Oxaliplatin
8
Fluorouracil
8
Nivolumab
7
Leucovorin
7
Paclitaxel
6
Capecitabine
5
Taxes
4
Specimen Handling
4
pembrolizumab
3
Trastuzumab
3
Ramucirumab
3
Magnetic Resonance Spectroscopy
3
Cisplatin
3
zimberelimab
2
zanidatamab
2
Radiotherapy
2
Folfox protocol
2
Carboplatin
2
zolbetuximab
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
tislelizumab
1
quemliclustat
1
obeticholic acid
1
futibatinib
1
dehydroftorafur
1
cixutumumab
1
balstilimab
1
Saline Solution
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Everolimus
×
30 days
×
Clear all
No trials found.